Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed5
Recruiting1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT07765134Completed
Comprehensive Kidney Function Assessment and Early Warning in Older Adults
Chronic Kidney DiseaseKidney FailureKidney Function Decline
PrincipalinvestigatorStart date: 2021-12-10
NCT07769190Completed
Cardiovascular Mortality Prediction in Maintenance Hemodialysis Patients
Cardiovascular DiseaseEnd-Stage Kidney Disease (ESKD)Secondary Hyperparathyroidism (SHPT)
PrincipalinvestigatorStart date: 2021-07-16
NCT04433455Recruiting
Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients
Cerebrovascular DisordersCognitive ImpairmentHemodialysis
PrincipalinvestigatorStart date: 2020-06-01
NCT03123406Phase 4Completed
Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
Hyperparathyroidism; Secondary, Renal
PrincipalinvestigatorStart date: 2017-04-19
NCT07466329Completed
Research and Validation of a Big Data-Driven Intelligent Decision-Making System for Hemodialysis
ESRD (End Stage Renal Disease)
PrincipalinvestigatorStart date: 2011-01-01
NCT06775067Completed
Incremental Dialysis Decision Model Based on Expert-Guided Machine Learning
End-stage Renal Disease
PrincipalinvestigatorStart date: 2010-04-12

Research Network

Collaboration Network

22 collaborators·69 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Li Zuo

Peking University People's Hospital

Related
4 trials

Shared therapeutic areas:

Chronic Kidney DiseasesHyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

Li Hao

The Second Hospital of Anhui Medial University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Yisheng Ling

Zhongshan Hospital Xiamen University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Junwei Yang

Second Affiliated Hospital of Nanjing Medical University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Chaosheng Chen

First Affiliated Hospital of Wenzhou Medical University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Jiazhuang Lou

The First Affiliated Hospital with Nanjing Medical University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Xiaonong Chen

Ruijin Hospital

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Aihua Zhang

Peking University Third Hospital

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Xuemei Li

Peking Union Medical College Hospital

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Qiang He

Sichuan Provincial People's Hospital

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT07765134PrincipalInvestigator

Comprehensive Kidney Function Assessment and Early Warning in Older Adults

Chronic Kidney DiseaseKidney FailureKidney Function Decline
Completed
NCT07769190PrincipalInvestigator

Cardiovascular Mortality Prediction in Maintenance Hemodialysis Patients

Cardiovascular DiseaseEnd-Stage Kidney Disease (ESKD)Secondary Hyperparathyroidism (SHPT)
Completed
NCT04433455PrincipalInvestigator

Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients

Cerebrovascular DisordersCognitive ImpairmentHemodialysis
Recruiting
NCT03123406Phase 4PrincipalInvestigator

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

Hyperparathyroidism; Secondary, Renal
Completed
NCT07466329PrincipalInvestigator

Research and Validation of a Big Data-Driven Intelligent Decision-Making System for Hemodialysis

ESRD (End Stage Renal Disease)
Completed
NCT06775067PrincipalInvestigator

Incremental Dialysis Decision Model Based on Expert-Guided Machine Learning

End-stage Renal Disease
Completed

All 6 trials loaded